Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nucleocytoplasmic carrier activity	KPNA4 NUP42 KPNA3	6.16e-05	32	48	3	GO:0140142
GeneOntologyMolecularFunction	disaccharide binding	LGALS9C LGALS9B	1.18e-04	7	48	2	GO:0048030
GeneOntologyMolecularFunction	glutamate-gated calcium ion channel activity	GRIA3 GRIN2A	1.57e-04	8	48	2	GO:0022849
GeneOntologyMolecularFunction	galactoside binding	LGALS9C LGALS9B	2.02e-04	9	48	2	GO:0016936
GeneOntologyMolecularFunction	glutamate-gated receptor activity	GRIA3 GRIN2A	7.52e-04	17	48	2	GO:0004970
GeneOntologyMolecularFunction	oligosaccharide binding	LGALS9C LGALS9B	1.05e-03	20	48	2	GO:0070492
GeneOntologyMolecularFunction	nuclear import signal receptor activity	KPNA4 KPNA3	1.05e-03	20	48	2	GO:0061608
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential	GRIA3 GRIN2A	1.51e-03	24	48	2	GO:0099507
GeneOntologyMolecularFunction	nuclear localization sequence binding	KPNA4 KPNA3	1.91e-03	27	48	2	GO:0008139
GeneOntologyMolecularFunction	glutamate receptor activity	GRIA3 GRIN2A	1.91e-03	27	48	2	GO:0008066
GeneOntologyMolecularFunction	poly(A) binding	TIA1 SYNCRIP	2.20e-03	29	48	2	GO:0008143
GeneOntologyMolecularFunction	molecular carrier activity	KPNA4 NUP42 KPNA3	2.23e-03	108	48	3	GO:0140104
GeneOntologyMolecularFunction	ligand-gated calcium channel activity	GRIA3 GRIN2A	2.52e-03	31	48	2	GO:0099604
GeneOntologyBiologicalProcess	negative regulation of CD4-positive, alpha-beta T cell proliferation	LGALS9C ITCH LGALS9B	5.28e-06	15	48	3	GO:2000562
GeneOntologyBiologicalProcess	negative regulation of alpha-beta T cell proliferation	LGALS9C ITCH LGALS9B	1.12e-05	19	48	3	GO:0046642
GeneOntologyBiologicalProcess	negative regulation of natural killer cell degranulation	LGALS9C LGALS9B	3.17e-05	4	48	2	GO:0043322
GeneOntologyBiologicalProcess	regulation of CD4-positive, alpha-beta T cell proliferation	LGALS9C ITCH LGALS9B	3.72e-05	28	48	3	GO:2000561
GeneOntologyBiologicalProcess	symbiont entry into host cell	ITCH CLEC5A WWP1 GSN KPNA3	4.48e-05	169	48	5	GO:0046718
GeneOntologyBiologicalProcess	CD4-positive, alpha-beta T cell proliferation	LGALS9C ITCH LGALS9B	4.59e-05	30	48	3	GO:0035739
GeneOntologyBiologicalProcess	positive regulation of regulatory T cell differentiation	LGALS9C LGALS9B GIMAP5	5.08e-05	31	48	3	GO:0045591
GeneOntologyBiologicalProcess	symbiont entry into host	ITCH CLEC5A WWP1 GSN KPNA3	5.44e-05	176	48	5	GO:0044409
GeneOntologyBiologicalProcess	regulation of CD4-positive, alpha-beta T cell activation	LGALS9C ITCH LGALS9B GIMAP5	8.59e-05	100	48	4	GO:2000514
GeneOntologyBiologicalProcess	negative regulation of CD4-positive, alpha-beta T cell activation	LGALS9C ITCH LGALS9B	1.10e-04	40	48	3	GO:2000515
GeneOntologyBiologicalProcess	viral life cycle	ITCH RESF1 CLEC5A WWP1 GSN KPNA3	1.31e-04	340	48	6	GO:0019058
GeneOntologyBiologicalProcess	regulation of natural killer cell degranulation	LGALS9C LGALS9B	1.47e-04	8	48	2	GO:0043321
GeneOntologyBiologicalProcess	biological process involved in symbiotic interaction	ITCH CLEC5A WWP1 CYSRT1 GSN KPNA3	1.56e-04	351	48	6	GO:0044403
GeneOntologyBiologicalProcess	biological process involved in interaction with host	ITCH CLEC5A WWP1 GSN KPNA3	1.84e-04	228	48	5	GO:0051701
GeneOntologyBiologicalProcess	regulation of regulatory T cell differentiation	LGALS9C LGALS9B GIMAP5	2.02e-04	49	48	3	GO:0045589
GeneOntologyBiologicalProcess	negative regulation of type II interferon production	LGALS9C LGALS9B GIMAP5	2.28e-04	51	48	3	GO:0032689
GeneOntologyBiologicalProcess	negative regulation of alpha-beta T cell activation	LGALS9C ITCH LGALS9B	2.41e-04	52	48	3	GO:0046636
GeneOntologyBiologicalProcess	regulation of alpha-beta T cell proliferation	LGALS9C ITCH LGALS9B	2.55e-04	53	48	3	GO:0046640
GeneOntologyBiologicalProcess	regulatory T cell differentiation	LGALS9C LGALS9B GIMAP5	2.70e-04	54	48	3	GO:0045066
GeneOntologyBiologicalProcess	negative regulation of cell-cell adhesion	LGALS9C ITCH LGALS9B GIMAP5 EPB41L5	2.92e-04	252	48	5	GO:0022408
GeneOntologyBiologicalProcess	regulation of alpha-beta T cell activation	LGALS9C ITCH LGALS9B GIMAP5	3.22e-04	141	48	4	GO:0046634
GeneOntologyBiologicalProcess	alpha-beta T cell proliferation	LGALS9C ITCH LGALS9B	3.51e-04	59	48	3	GO:0046633
GeneOntologyBiologicalProcess	negative regulation of response to biotic stimulus	LGALS9C ITCH LGALS9B AHR	4.18e-04	151	48	4	GO:0002832
GeneOntologyBiologicalProcess	CD4-positive, alpha-beta T cell activation	LGALS9C ITCH LGALS9B GIMAP5	4.39e-04	153	48	4	GO:0035710
GeneOntologyBiologicalProcess	positive regulation of chromatin organization	RESF1 TAL1	4.74e-04	14	48	2	GO:1905269
GeneOntologyBiologicalProcess	activation of cysteine-type endopeptidase activity	ASPH GRIN2A	5.46e-04	15	48	2	GO:0097202
GeneOntologyBiologicalProcess	negative regulation of natural killer cell activation	LGALS9C LGALS9B	5.46e-04	15	48	2	GO:0032815
GeneOntologyBiologicalProcess	negative regulation of T cell activation	LGALS9C ITCH LGALS9B GIMAP5	6.68e-04	171	48	4	GO:0050868
GeneOntologyBiologicalProcess	viral process	ITCH RESF1 CLEC5A WWP1 GSN KPNA3	6.92e-04	464	48	6	GO:0016032
GeneOntologyBiologicalProcess	negative regulation of leukocyte degranulation	LGALS9C LGALS9B	7.05e-04	17	48	2	GO:0043301
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated cytotoxicity	LGALS9C LGALS9B GIMAP5	7.38e-04	76	48	3	GO:0042269
GeneOntologyBiologicalProcess	natural killer cell degranulation	LGALS9C LGALS9B	7.92e-04	18	48	2	GO:0043320
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated immunity	LGALS9C LGALS9B GIMAP5	8.57e-04	80	48	3	GO:0002715
GeneOntologyBiologicalProcess	positive regulation of defense response to bacterium	LGALS9C LGALS9B	8.84e-04	19	48	2	GO:1900426
GeneOntologyBiologicalProcess	receptor metabolic process	ITCH GRIA3 GRIN2A	9.21e-04	82	48	3	GO:0043112
GeneOntologyBiologicalProcess	receptor clustering	LGALS9C LGALS9B GSN	9.54e-04	83	48	3	GO:0043113
GeneOntologyBiologicalProcess	negative regulation of lymphocyte mediated immunity	LGALS9C LGALS9B AHR	9.54e-04	83	48	3	GO:0002707
GeneOntologyBiologicalProcess	NLS-bearing protein import into nucleus	KPNA4 KPNA3	9.81e-04	20	48	2	GO:0006607
GeneOntologyBiologicalProcess	regulation of T cell chemotaxis	LGALS9C LGALS9B	9.81e-04	20	48	2	GO:0010819
GeneOntologyBiologicalProcess	negative regulation of leukocyte cell-cell adhesion	LGALS9C ITCH LGALS9B GIMAP5	1.03e-03	192	48	4	GO:1903038
GeneOntologyBiologicalProcess	mesoderm morphogenesis	SETD2 EPB41L5 TAL1	1.06e-03	86	48	3	GO:0048332
GeneOntologyBiologicalProcess	regulation of natural killer cell differentiation	LGALS9C LGALS9B	1.08e-03	21	48	2	GO:0032823
GeneOntologyBiologicalProcess	positive regulation of calcium ion transport into cytosol	GIMAP5 ASPH	1.08e-03	21	48	2	GO:0010524
GeneOntologyBiologicalProcess	T cell activation	LGALS9C ITCH CEACAM21 LGALS9B GIMAP5 WWP1 GSN	1.11e-03	701	48	7	GO:0042110
GeneOntologyBiologicalProcess	mRNA splicing, via spliceosome	TIA1 BUD13 HNRNPUL1 SYNCRIP HNRNPR	1.42e-03	358	48	5	GO:0000398
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	TIA1 BUD13 HNRNPUL1 SYNCRIP HNRNPR	1.42e-03	358	48	5	GO:0000377
GeneOntologyBiologicalProcess	negative regulation of leukocyte mediated immunity	LGALS9C LGALS9B AHR	1.45e-03	96	48	3	GO:0002704
GeneOntologyBiologicalProcess	negative regulation of lymphocyte activation	LGALS9C ITCH LGALS9B GIMAP5	1.46e-03	211	48	4	GO:0051250
GeneOntologyBiologicalProcess	gastrulation	SETD2 EPB41L5 TAL1 LMBRD1	1.48e-03	212	48	4	GO:0007369
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions	TIA1 BUD13 HNRNPUL1 SYNCRIP HNRNPR	1.49e-03	362	48	5	GO:0000375
GeneOntologyBiologicalProcess	regulation of calcium ion transmembrane transport	GIMAP5 ASPH TSPAN13 AHR	1.64e-03	218	48	4	GO:1903169
GeneOntologyBiologicalProcess	regulation of defense response to bacterium	LGALS9C LGALS9B	1.66e-03	26	48	2	GO:1900424
GeneOntologyBiologicalProcess	lymphocyte activation	LGALS9C ITCH CEACAM21 LGALS9B GIMAP5 WWP1 AHR GSN	1.71e-03	976	48	8	GO:0046649
GeneOntologyBiologicalProcess	negative regulation of cell adhesion	LGALS9C ITCH LGALS9B GIMAP5 EPB41L5	1.74e-03	375	48	5	GO:0007162
GeneOntologyBiologicalProcess	ionotropic glutamate receptor signaling pathway	GRIA3 GRIN2A	1.79e-03	27	48	2	GO:0035235
GeneOntologyBiologicalProcess	regulation of calcium ion transport into cytosol	GIMAP5 ASPH	1.79e-03	27	48	2	GO:0010522
GeneOntologyBiologicalProcess	hemopoiesis	LGALS9C ITCH LGALS9B GIMAP5 CLEC5A WWP1 AHR TAL1 GABPA	1.81e-03	1223	48	9	GO:0030097
GeneOntologyBiologicalProcess	regulation of monoatomic cation transmembrane transport	GIMAP5 ASPH TSPAN13 AHR GRIN2A	1.85e-03	380	48	5	GO:1904062
GeneOntologyBiologicalProcess	natural killer cell mediated cytotoxicity	LGALS9C LGALS9B GIMAP5	1.88e-03	105	48	3	GO:0042267
GeneOntologyBiologicalProcess	regulation of protein depolymerization	SPTBN5 ASPH GSN	1.88e-03	105	48	3	GO:1901879
GeneOntologyBiologicalProcess	alpha-beta T cell activation	LGALS9C ITCH LGALS9B GIMAP5	1.90e-03	227	48	4	GO:0046631
GeneOntologyBiologicalProcess	negative regulation of T cell proliferation	LGALS9C ITCH LGALS9B	1.98e-03	107	48	3	GO:0042130
GeneOntologyBiologicalProcess	regulation of lymphocyte mediated immunity	LGALS9C LGALS9B GIMAP5 AHR	2.06e-03	232	48	4	GO:0002706
GeneOntologyBiologicalProcess	natural killer cell mediated immunity	LGALS9C LGALS9B GIMAP5	2.09e-03	109	48	3	GO:0002228
GeneOntologyBiologicalProcess	calcium ion transmembrane transport	GIMAP5 ASPH TSPAN13 AHR GRIN2A	2.12e-03	392	48	5	GO:0070588
GeneOntologyBiologicalProcess	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	LGALS9C LGALS9B GIMAP5 AHR	2.16e-03	235	48	4	GO:0002822
GeneOntologyBiologicalProcess	maintenance of location	LGALS9C LGALS9B ASPH APOB GSN	2.21e-03	396	48	5	GO:0051235
GeneOntologyBiologicalProcess	maintenance of protein location	LGALS9C LGALS9B GSN	2.26e-03	112	48	3	GO:0045185
GeneOntologyBiologicalProcess	negative regulation of leukocyte activation	LGALS9C ITCH LGALS9B GIMAP5	2.33e-03	240	48	4	GO:0002695
GeneOntologyBiologicalProcess	regulation of lymphocyte chemotaxis	LGALS9C LGALS9B	2.36e-03	31	48	2	GO:1901623
GeneOntologyBiologicalProcess	positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	LGALS9C ELAPOR2 LGALS9B	2.43e-03	115	48	3	GO:0090100
GeneOntologyBiologicalProcess	negative regulation of regulated secretory pathway	LGALS9C LGALS9B	2.52e-03	32	48	2	GO:1903306
GeneOntologyCellularComponent	NLS-dependent protein nuclear import complex	KPNA4 KPNA3	2.39e-04	10	49	2	GO:0042564
GeneOntologyCellularComponent	nucleocytoplasmic transport complex	KPNA4 KPNA3	3.50e-04	12	49	2	GO:0031074
Domain	HnRNP_R/Q_splicing_fac	SYNCRIP HNRNPR	6.44e-05	5	48	2	IPR006535
Domain	Arm_3	KPNA4 KPNA3	1.35e-04	7	48	2	PF16186
Domain	Importing_su_alpha	KPNA4 KPNA3	1.35e-04	7	48	2	IPR024931
Domain	Arm_3	KPNA4 KPNA3	1.35e-04	7	48	2	IPR032413
Domain	IBB	KPNA4 KPNA3	1.35e-04	7	48	2	PF01749
Domain	IBB	KPNA4 KPNA3	1.79e-04	8	48	2	PS51214
Domain	Importin-a_IBB	KPNA4 KPNA3	2.30e-04	9	48	2	IPR002652
Domain	WW	SETD2 ITCH WWP1	2.39e-04	47	48	3	PF00397
Domain	WW	SETD2 ITCH WWP1	2.54e-04	48	48	3	SM00456
Domain	WW_DOMAIN_2	SETD2 ITCH WWP1	3.04e-04	51	48	3	PS50020
Domain	WW_DOMAIN_1	SETD2 ITCH WWP1	3.04e-04	51	48	3	PS01159
Domain	WW_dom	SETD2 ITCH WWP1	3.22e-04	52	48	3	IPR001202
Domain	Gal-bind_lectin	LGALS9C LGALS9B	6.65e-04	15	48	2	PF00337
Domain	Gal-bind_lectin	LGALS9C LGALS9B	6.65e-04	15	48	2	SM00908
Domain	GALECTIN	LGALS9C LGALS9B	6.65e-04	15	48	2	PS51304
Domain	Galectin_CRD	LGALS9C LGALS9B	6.65e-04	15	48	2	IPR001079
Domain	GLECT	LGALS9C LGALS9B	6.65e-04	15	48	2	SM00276
Domain	Iontro_rcpt	GRIA3 GRIN2A	9.64e-04	18	48	2	IPR001320
Domain	Lig_chan-Glu_bd	GRIA3 GRIN2A	9.64e-04	18	48	2	PF10613
Domain	Iono_rcpt_met	GRIA3 GRIN2A	9.64e-04	18	48	2	IPR001508
Domain	Glu/Gly-bd	GRIA3 GRIN2A	9.64e-04	18	48	2	IPR019594
Domain	Lig_chan-Glu_bd	GRIA3 GRIN2A	9.64e-04	18	48	2	SM00918
Domain	Lig_chan	GRIA3 GRIN2A	9.64e-04	18	48	2	PF00060
Domain	PBPe	GRIA3 GRIN2A	9.64e-04	18	48	2	SM00079
Domain	HECT	ITCH WWP1	2.18e-03	27	48	2	PF00632
Domain	HECTc	ITCH WWP1	2.18e-03	27	48	2	SM00119
Domain	HECT_dom	ITCH WWP1	2.18e-03	27	48	2	IPR000569
Domain	HECT	ITCH WWP1	2.18e-03	27	48	2	PS50237
Domain	Arm	KPNA4 KPNA3	2.87e-03	31	48	2	PF00514
Domain	ANF_lig-bd_rcpt	GRIA3 GRIN2A	4.07e-03	37	48	2	IPR001828
Domain	ANF_receptor	GRIA3 GRIN2A	4.07e-03	37	48	2	PF01094
Domain	Peripla_BP_I	GRIA3 GRIN2A	4.51e-03	39	48	2	IPR028082
Domain	ARM_REPEAT	KPNA4 KPNA3	4.74e-03	40	48	2	PS50176
Domain	ARM	KPNA4 KPNA3	4.74e-03	40	48	2	SM00185
Domain	Armadillo	KPNA4 KPNA3	6.49e-03	47	48	2	IPR000225
Pathway	REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS	KPNA4 NUP42 KPNA3	1.66e-04	41	37	3	M29574
Pathway	REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING	ITCH WWP1	2.39e-04	9	37	2	M26930
Pathway	REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING	ITCH WWP1	2.39e-04	9	37	2	MM14535
Pubmed	SARS-Cov-2 spike induces intestinal barrier dysfunction through the interaction between CEACAM5 and Galectin-9.	LGALS9C CEACAM21 LGALS9B	1.19e-08	4	51	3	38686388
Pubmed	Genetic loss of importin α4 causes abnormal sperm morphology and impacts on male fertility in mouse.	KPNA4 KPNA3	2.11e-06	2	51	2	33058343
Pubmed	Cellular Importin-α3 Expression Dynamics in the Lung Regulate Antiviral Response Pathways against Influenza A Virus Infection.	KPNA4 KPNA3	2.11e-06	2	51	2	32320654
Pubmed	Japanese Encephalitis Virus NS5 Inhibits Type I Interferon (IFN) Production by Blocking the Nuclear Translocation of IFN Regulatory Factor 3 and NF-κB.	KPNA4 KPNA3	2.11e-06	2	51	2	28179530
Pubmed	Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis.	LGALS9C LGALS9B	6.32e-06	3	51	2	29458010
Pubmed	Genetic heterogeneity of plasma lipoproteins in the mouse: control of low density lipoprotein particle sizes by genetic factors.	AHR APOB	6.32e-06	3	51	2	1971301
Pubmed	Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation.	LGALS9C LGALS9B	6.32e-06	3	51	2	19776007
Pubmed	Cooperative Interactions of Oligosaccharide and Peptide Moieties of a Glycopeptide Derived from IgE with Galectin-9.	LGALS9C LGALS9B	6.32e-06	3	51	2	26582205
Pubmed	Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin.	LGALS9C LGALS9B	6.32e-06	3	51	2	9153289
Pubmed	Galectin-9 regulates follicular helper T cells to inhibit humoral autoimmunity-induced pulmonary fibrosis.	LGALS9C LGALS9B	6.32e-06	3	51	2	33316546
Pubmed	Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice.	LGALS9C LGALS9B	6.32e-06	3	51	2	18974023
Pubmed	Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin.	LGALS9C LGALS9B	6.32e-06	3	51	2	9038233
Pubmed	Assignment of a gene encoding ornithine decarboxylase to the proximal region of chromosome 12 in the mouse.	AHR APOB	6.32e-06	3	51	2	2627199
Pubmed	Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion.	LGALS9C LGALS9B	6.32e-06	3	51	2	23144904
Pubmed	Nuclear localization signal in a cancer-related transcriptional regulator protein NAC1.	KPNA4 KPNA3	6.32e-06	3	51	2	22665369
Pubmed	Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings.	LGALS9C LGALS9B	6.32e-06	3	51	2	29651447
Pubmed	Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production.	LGALS9C LGALS9B	6.32e-06	3	51	2	28704475
Pubmed	Serum Glycoprotein Biomarker Discovery and Qualification Pipeline Reveals Novel Diagnostic Biomarker Candidates for Esophageal Adenocarcinoma.	APOB GSN	6.32e-06	3	51	2	26404905
Pubmed	The N- and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity.	LGALS9C LGALS9B	6.32e-06	3	51	2	21146220
Pubmed	Cell fate regulation by gelsolin in human gynecologic cancers.	ITCH GSN	6.32e-06	3	51	2	25246592
Pubmed	Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis.	LGALS9C LGALS9B	6.32e-06	3	51	2	23836896
Pubmed	Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes.	LGALS9C LGALS9B	6.32e-06	3	51	2	7890611
Pubmed	Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner.	LGALS9C LGALS9B	6.32e-06	3	51	2	22341088
Pubmed	Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9.	LGALS9C LGALS9B	6.32e-06	3	51	2	28990062
Pubmed	Galectin-9 Is a Novel Regulator of Epithelial Restitution.	LGALS9C LGALS9B	6.32e-06	3	51	2	32380082
Pubmed	Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts.	LGALS9C LGALS9B	6.32e-06	3	51	2	23667648
Pubmed	Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.	LGALS9C LGALS9B	6.32e-06	3	51	2	18579572
Pubmed	Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.	LGALS9C LGALS9B	6.32e-06	3	51	2	28877989
Pubmed	Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages.	LGALS9C LGALS9B	6.32e-06	3	51	2	19800850
Pubmed	The effect of Toxoplasma gondii infection on galectin-9 expression in decidual macrophages contributing to dysfunction of decidual NK cells during pregnancy.	LGALS9C LGALS9B	6.32e-06	3	51	2	38987795
Pubmed	Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS.	SYNCRIP HNRNPR	6.32e-06	3	51	2	30755280
Pubmed	Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition.	LGALS9C LGALS9B	6.32e-06	3	51	2	16990264
Pubmed	Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue.	LGALS9C LGALS9B	6.32e-06	3	51	2	18005988
Pubmed	Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.	LGALS9C LGALS9B	6.32e-06	3	51	2	23585851
Pubmed	Dynamics of alternative splicing during somatic cell reprogramming reveals functions for RNA-binding proteins CPSF3, hnRNP UL1, and TIA1.	TIA1 HNRNPUL1	6.32e-06	3	51	2	34082786
Pubmed	Galectin-9 ameliorates anti-GBM glomerulonephritis by inhibiting Th1 and Th17 immune responses in mice.	LGALS9C LGALS9B	6.32e-06	3	51	2	24477688
Pubmed	A unique role for galectin-9 in angiogenesis and inflammatory arthritis.	LGALS9C LGALS9B	6.32e-06	3	51	2	29433546
Pubmed	Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.	LGALS9C LGALS9B	6.32e-06	3	51	2	37105392
Pubmed	Adenovirus protein involved in virus internalization recruits ubiquitin-protein ligases.	ITCH WWP1	6.32e-06	3	51	2	12450395
Pubmed	Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson's disease.	LGALS9C LGALS9B	6.32e-06	3	51	2	36479526
Pubmed	Profiling Lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy.	LGALS9C LGALS9B	6.32e-06	3	51	2	23242525
Pubmed	Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice.	LGALS9C LGALS9B	6.32e-06	3	51	2	19851072
Pubmed	The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes.	LGALS9C LGALS9B	6.32e-06	3	51	2	33923930
Pubmed	Karyopherin α 3 and karyopherin α 4 proteins mediate the nuclear import of methyl-CpG binding protein 2.	KPNA4 KPNA3	6.32e-06	3	51	2	26245896
Pubmed	Alarmin function of galectin-9 in murine respiratory tularemia.	LGALS9C LGALS9B	6.32e-06	3	51	2	25898318
Pubmed	Amelioration of bleomycin-induced pulmonary fibrosis via TGF-β-induced Smad and non-Smad signaling pathways in galectin-9-deficient mice and fibroblast cells.	LGALS9C LGALS9B	6.32e-06	3	51	2	31937306
Pubmed	Intestinal epithelial cells express galectin-9 in patients with food allergy that plays a critical role in sustaining allergic status in mouse intestine.	LGALS9C LGALS9B	6.32e-06	3	51	2	21426359
Pubmed	Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases.	LGALS9C LGALS9B	6.32e-06	3	51	2	31969388
Pubmed	Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis.	LGALS9C LGALS9B	6.32e-06	3	51	2	18282810
Pubmed	Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia.	LGALS9C LGALS9B	6.32e-06	3	51	2	35241678
Pubmed	Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations.	LGALS9C LGALS9B	6.32e-06	3	51	2	24083426
Pubmed	Galectin-9 in synergy with NF-κB inhibition restores immune regulatory capability in dendritic cells of subjects with food allergy.	LGALS9C LGALS9B	6.32e-06	3	51	2	37279535
Pubmed	The protective function of galectin-9 in liver ischemia and reperfusion injury in mice.	LGALS9C LGALS9B	6.32e-06	3	51	2	25931247
Pubmed	Possible regulatory role of galectin-9 on Ascaris suum-induced eosinophilic lung inflammation in mice.	LGALS9C LGALS9B	6.32e-06	3	51	2	22627368
Pubmed	Galectin-9 is required for endometrial regenerative cells to induce long-term cardiac allograft survival in mice.	LGALS9C LGALS9B	6.32e-06	3	51	2	33153471
Pubmed	T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses.	LGALS9C LGALS9B	6.32e-06	3	51	2	22052881
Pubmed	Interaction of tissue transglutaminase with nuclear transport protein importin-alpha3.	KPNA4 KPNA3	6.32e-06	3	51	2	10100610
Pubmed	Galectin-9 protects mice from the Shwartzman reaction by attracting prostaglandin E2-producing polymorphonuclear leukocytes.	LGALS9C LGALS9B	6.32e-06	3	51	2	17560833
Pubmed	Galectin-9 supports primary T cell transendothelial migration in a glycan and integrin dependent manner.	LGALS9C LGALS9B	6.32e-06	3	51	2	35643073
Pubmed	Galectin-9 functionally impairs natural killer cells in humans and mice.	LGALS9C LGALS9B	6.32e-06	3	51	2	23408620
Pubmed	Importin α3 regulates chronic pain pathways in peripheral sensory neurons.	KPNA4 KPNA3	1.26e-05	4	51	2	32792398
Pubmed	Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.	LGALS9C LGALS9B	1.26e-05	4	51	2	22677125
Pubmed	Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators.	LGALS9C LGALS9B	1.26e-05	4	51	2	19234217
Pubmed	MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection.	KPNA4 KPNA3	1.26e-05	4	51	2	29370303
Pubmed	Prohibitin inhibits tumor necrosis factor alpha-induced nuclear factor-kappa B nuclear translocation via the novel mechanism of decreasing importin alpha3 expression.	KPNA4 KPNA3	1.26e-05	4	51	2	19710421
Pubmed	Endogenous spartin (SPG20) is recruited to endosomes and lipid droplets and interacts with the ubiquitin E3 ligases AIP4 and AIP5.	ITCH WWP1	1.26e-05	4	51	2	19580544
Pubmed	Tim-3/Galectin-9 signaling pathway is involved in the cytokine changes in mice with alveolar echinococcosis.	LGALS9C LGALS9B	1.26e-05	4	51	2	35715604
Pubmed	Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.	LGALS9C LGALS9B	1.26e-05	4	51	2	19017954
Pubmed	Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation.	LGALS9C LGALS9B	1.26e-05	4	51	2	33963043
Pubmed	Galectin-9: A novel promoter of atherosclerosis progression.	LGALS9C LGALS9B	1.26e-05	4	51	2	36459823
Pubmed	Newly characterized decidual Tim-3+ Treg cells are abundant during early pregnancy and driven by IL-27 coordinately with Gal-9 from trophoblasts.	LGALS9C LGALS9B	1.26e-05	4	51	2	33107565
Pubmed	Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models.	LGALS9C LGALS9B	1.26e-05	4	51	2	29611821
Pubmed	Lipopolysaccharide mediates time-dependent macrophage M1/M2 polarization through the Tim-3/Galectin-9 signalling pathway.	LGALS9C LGALS9B	1.26e-05	4	51	2	30763585
Pubmed	Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2.	LGALS9C LGALS9B	1.26e-05	4	51	2	33727589
Pubmed	Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells.	LGALS9C LGALS9B	1.26e-05	4	51	2	19362679
Pubmed	The Galectin-9/Tim-3 pathway is involved in the regulation of NK cell function at the maternal-fetal interface in early pregnancy.	LGALS9C LGALS9B	1.26e-05	4	51	2	25578313
Pubmed	Intestinal Lamina Propria CD4+ T Cells Promote Bactericidal Activity of Macrophages via Galectin-9 and Tim-3 Interaction during Salmonella enterica Serovar Typhimurium Infection.	LGALS9C LGALS9B	1.26e-05	4	51	2	29844236
Pubmed	Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response.	LGALS9C LGALS9B	1.26e-05	4	51	2	20463811
Pubmed	Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons?	SYNCRIP HNRNPR	1.26e-05	4	51	2	11773003
Pubmed	Lumenal Galectin-9-Lamp2 interaction regulates lysosome and autophagy to prevent pathogenesis in the intestine and pancreas.	LGALS9C LGALS9B	1.26e-05	4	51	2	32855403
Pubmed	Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain.	LGALS9C LGALS9B	1.26e-05	4	51	2	23657851
Pubmed	The Ubiquitin Ligase Itch and Ubiquitination Regulate BFRF1-Mediated Nuclear Envelope Modification for Epstein-Barr Virus Maturation.	ITCH WWP1	1.26e-05	4	51	2	27466427
Pubmed	Disinhibition of the HECT E3 ubiquitin ligase WWP2 by polymerized Dishevelled.	ITCH WWP1	1.26e-05	4	51	2	26701932
Pubmed	Subcellular distribution of importins correlates with germ cell maturation.	KPNA4 KPNA3	1.26e-05	4	51	2	17654710
Pubmed	Cloning of two novel human importin-alpha subunits and analysis of the expression pattern of the importin-alpha protein family.	KPNA4 KPNA3	1.26e-05	4	51	2	9395085
Pubmed	[Expression and significance of galectin-3 and galectin-9 in mice nasal mucosa with allergic rhinitis].	LGALS9C LGALS9B	1.26e-05	4	51	2	18826117
Pubmed	Genetic factors controlling structure and expression of apolipoproteins B and E in mice.	AHR APOB	1.26e-05	4	51	2	3034900
Pubmed	The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.	LGALS9C LGALS9B	1.26e-05	4	51	2	24333756
Pubmed	The expression of Galectin-9 correlates with mTOR and AMPK in murine colony-forming erythroid progenitors.	LGALS9C LGALS9B	1.26e-05	4	51	2	38853593
Pubmed	SMN interacts with a novel family of hnRNP and spliceosomal proteins.	SYNCRIP HNRNPR	1.26e-05	4	51	2	11574476
Pubmed	Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies.	LGALS9C LGALS9B	1.26e-05	4	51	2	24958847
Pubmed	Galectin-9 binds IgM-BCR to regulate B cell signaling.	LGALS9C LGALS9B	1.26e-05	4	51	2	30120235
Pubmed	[Expression of Galectin-9 and Tim-3 in lungs of mice with asthma].	LGALS9C LGALS9B	1.26e-05	4	51	2	21575348
Pubmed	Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts.	LGALS9C LGALS9B	1.26e-05	4	51	2	18346632
Pubmed	Isolation and characterization of a novel eosinophil-specific galectin released into the lungs in response to allergen challenge.	LGALS9C LGALS9B	1.26e-05	4	51	2	11839756
Pubmed	Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice.	LGALS9C LGALS9B	1.26e-05	4	51	2	19670381
Pubmed	Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.	LGALS9C LGALS9B	1.26e-05	4	51	2	25450716
Pubmed	The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity.	LGALS9C LGALS9B	1.26e-05	4	51	2	16286920
Pubmed	Galectin-9 regulates the threshold of B cell activation and autoimmunity.	LGALS9C LGALS9B	1.26e-05	4	51	2	34369876
Pubmed	Targeting the CD146/Galectin-9 axis protects the integrity of the blood-brain barrier in experimental cerebral malaria.	LGALS9C LGALS9B	1.26e-05	4	51	2	33203936
Cytoband	7p15	AHR NUP42	1.09e-04	14	51	2	7p15
Cytoband	12p11.21	RESF1 OVOS2	2.76e-04	22	51	2	12p11.21
Cytoband	17p11.2	LGALS9C LGALS9B PLD6	7.51e-04	159	51	3	17p11.2
Cytoband	Ensembl 112 genes in cytogenetic band chr17p11	LGALS9C LGALS9B PLD6	1.52e-03	203	51	3	chr17p11
GeneFamily	Galectins	LGALS9C LGALS9B	3.55e-04	15	34	2	629
GeneFamily	Armadillo repeat containing\|Importins	KPNA4 KPNA3	5.15e-04	18	34	2	596
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	KPNA4 KPNA3	2.95e-03	43	34	2	409
GeneFamily	RNA binding motif containing	TIA1 SYNCRIP HNRNPR	7.37e-03	213	34	3	725
GeneFamily	Basic helix-loop-helix proteins	AHR TAL1	1.81e-02	110	34	2	420
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-goblet\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LGALS9C LGALS9B ASPH TSPAN13 GSN	2.98e-06	196	51	5	c2d17630f7bfc9e727de55e093c17fddac61b61f
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-goblet-Goblet_cell\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LGALS9C LGALS9B ASPH TSPAN13 GSN	2.98e-06	196	51	5	54c30023d04e7265373647f56fc93885804938b0
ToppCell	PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CEACAM21 GUCY1A2 GLB1L3 CLEC5A	2.18e-05	143	51	4	9836a040a2ebcf6f05431e658a7b8fd566621452
ToppCell	PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CEACAM21 GUCY1A2 GLB1L3 CLEC5A	2.18e-05	143	51	4	4622c221b5d2d4cd4f37e4f81662e073924e1507
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TSPAN13 AHR TNS1 GSN	4.79e-05	175	51	4	282f09bbdfa70d93b3f66591dcfb84c5ee0268c7
ToppCell	P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	WWP1 EPB41L5 TNS1 GSN	4.90e-05	176	51	4	f3a54038cde58326f1caed96ecca33c141bcc8b3
ToppCell	droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASPH GRIA3 RILPL1 TNS1	5.23e-05	179	51	4	d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159
ToppCell	AT1_cells-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	TSPAN13 EPB41L5 C1orf167 TNS1	5.35e-05	180	51	4	2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2
ToppCell	E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	GIMAP5 TSPAN13 AHR TAL1	5.58e-05	182	51	4	fec1caf867b1dc87b24504d895ee1a27df78062e
ToppCell	3'_v3-bone_marrow-Hematopoietic_Erythro-Mega-Mega-Mast\|bone_marrow / Manually curated celltypes from each tissue	RUSC1 APOB TAL1 GSN	5.82e-05	184	51	4	030d5ef5e44e4d973862128fe01f7e8ef0092a06
ToppCell	Mild-NK\|World / Disease group and Cell class	LGALS9C LGALS9B MAML3 GSN	5.95e-05	185	51	4	0565b7c464e1a09e596f5a0b363d2dc9b55c3c50
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	RESF1 WWP1 BIRC6 GABPA	6.07e-05	186	51	4	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	AT1-AT2_cells-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	TSPAN13 EPB41L5 C1orf167 TNS1	6.33e-05	188	51	4	be710bc957118cf426dd71c2d57e6f1b41c9a467
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSPAN13 EPB41L5 C1orf167 TNS1	6.59e-05	190	51	4	8ceb327dc995f4b83b05d5d6630e1294f0cb49bd
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSPAN13 EPB41L5 C1orf167 TNS1	6.73e-05	191	51	4	a15e34ad7dbf3f2f13d5e23ce3ffb6d08fd1f9f0
ToppCell	E16.5-samps-Endothelial-Immature_fetal_endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	GIMAP5 TSPAN13 AHR TAL1	6.73e-05	191	51	4	44c596984c6196f6014e0e405dbe5560841e54ff
ToppCell	E16.5-samps-Endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	GIMAP5 TSPAN13 AHR TAL1	6.73e-05	191	51	4	e7521d4d24f016d4e531cd492a7a69604f0c9e6f
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GUCY1A2 GRIN2A RILPL1 TNS1	7.01e-05	193	51	4	2483bb7f398e4fa0ef09c8bd584ed25703853f03
ToppCell	facs-Bladder-nan-3m-Epithelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RESF1 COX6B1 ASPH EPB41L5	7.15e-05	194	51	4	e74cd8cf3763f6adbfd1c269a886a806049714cf
ToppCell	3'-Adult-LargeIntestine-Epithelial-goblet\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LGALS9C LGALS9B TSPAN13 GSN	7.15e-05	194	51	4	1a188e52f2f0b6eca3e8d4a4671d9beab0fbbb88
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LGALS9C LGALS9B TSPAN13 GSN	7.29e-05	195	51	4	c5f33b420c9ac14dc67fea632b8c2bc2442cbf3d
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSPAN13 EPB41L5 C1orf167 TNS1	7.29e-05	195	51	4	68f4cc84b5ae7f4159b780c78e4b66c94211779a
ToppCell	normal_Lung-Epithelial_cells-AT1\|normal_Lung / Location, Cell class and cell subclass	TSPAN13 EPB41L5 C1orf167 TNS1	7.29e-05	195	51	4	569d1ebc5a5aa110a2430b096755ae35354040c4
ToppCell	3'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LGALS9C LGALS9B TSPAN13 GSN	7.29e-05	195	51	4	3365768101454060b9ea96ef6b426c76c150bc8f
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSPAN13 EPB41L5 C1orf167 TNS1	7.29e-05	195	51	4	2a1863f4b9fe73c30b0b1acf9b12fc98ef65040f
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-Goblet_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LGALS9C LGALS9B TSPAN13 GSN	7.29e-05	195	51	4	219c5d0cde7f6082755154f54db221413ec555cb
ToppCell	COVID-19_Severe-PLT_4\|World / Disease Group and Platelet Clusters	DENND4A RESF1 TIA1 AHR	7.44e-05	196	51	4	ad43efdd4d73b6615f65f06a315b33576e317473
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSPAN13 EPB41L5 C1orf167 TNS1	7.44e-05	196	51	4	eb68f7954e7c2f86d05e740e95b6e74805a6053f
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSPAN13 EPB41L5 C1orf167 TNS1	7.58e-05	197	51	4	c9c968e223e7814cd8d22975d849a31b7e0af7aa
ToppCell	ASK452-Epithelial-Type_1\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	TSPAN13 AHR EPB41L5 TNS1	7.58e-05	197	51	4	dc0a6dca4af6b216357b06f67203274f8b2a8bb0
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSPAN13 EPB41L5 C1orf167 TNS1	7.58e-05	197	51	4	734b8db5bb4917c9ce92ed342fe6c22b64b0d3c5
ToppCell	normal_Lung-Epithelial_cells-AT1\|Epithelial_cells / Location, Cell class and cell subclass	TSPAN13 EPB41L5 C1orf167 TNS1	7.58e-05	197	51	4	7d19b93d6853828e2a036e37c4887edb1de4503c
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSPAN13 EPB41L5 C1orf167 TNS1	7.58e-05	197	51	4	e344455e62b3fe94bb242dc0db58d19a1d3878c7
ToppCell	Biopsy_IPF-Epithelial-AT1\|Biopsy_IPF / Sample group, Lineage and Cell type	TSPAN13 EPB41L5 C1orf167 TNS1	7.73e-05	198	51	4	75bdecbe111fededf6082b11de18b84ca308ef6d
ToppCell	COVID-19_Severe-PLT_4\|COVID-19_Severe / Disease Group and Platelet Clusters	DENND4A RESF1 TIA1 AHR	7.73e-05	198	51	4	abfddbee99ef8c7719e6e6f62571e9be030e4acf
ToppCell	10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-myelocyte\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CEACAM21 CLEC5A BLOC1S1 GSN	7.73e-05	198	51	4	3bc05b8d97a7219af40db7a11aa271f02e74fca5
ToppCell	Sigmoid-T_cell-Tcm\|T_cell / Region, Cell class and subclass	LGALS9C LGALS9B BUD13 PLD6	7.89e-05	199	51	4	acdf95f4d58df47690f4ae254245bc618f9ac07e
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CLEC5A AHR TNS1 MAML3	7.89e-05	199	51	4	379bbd9cecf466b902411c54d74bd9885285b1ba
ToppCell	proximal-Epithelial-Alveolar_Epithelial_Type_1-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TSPAN13 EPB41L5 C1orf167 TNS1	8.04e-05	200	51	4	b652bc73adfdeccbdcd74497ab6e2085e5c95e88
ToppCell	distal-3-Epithelial-Alveolar_Epithelial_Type_1\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TSPAN13 EPB41L5 C1orf167 TNS1	8.04e-05	200	51	4	ff64454a08ae8d4cc6e8f0392558460020844bbc
ToppCell	proximal-Epithelial-Alveolar_Epithelial_Type_1\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TSPAN13 EPB41L5 C1orf167 TNS1	8.04e-05	200	51	4	c1345893e6947ccf9b41282d0e4428dbfb8bcc27
ToppCell	proximal-3-Epithelial-Alveolar_Epithelial_Type_1\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TSPAN13 EPB41L5 C1orf167 TNS1	8.04e-05	200	51	4	51f8fc43c069f2c4e75588d28ae6deb5d7ed2c86
Disease	level of Diacylglycerol (18:1_18:1) in blood serum	BUD13 APOB	1.35e-04	11	47	2	OBA_2045170
Disease	integral membrane protein 2B measurement	BUD13 APOB	1.62e-04	12	47	2	EFO_0802634
Disease	Fetal Alcohol Syndrome	ERCC6L GABPA	3.33e-04	17	47	2	C0015923
Disease	cerebral infarction (is_marker_for)	APOB GSN	4.17e-04	19	47	2	DOID:3526 (is_marker_for)
Disease	Dyslipidemias	AHR APOB	6.70e-04	24	47	2	C0242339
Disease	Dyslipoproteinemias	AHR APOB	6.70e-04	24	47	2	C0598784
Disease	Behcet Syndrome	AHR APOB	6.70e-04	24	47	2	C0004943
Disease	coronary artery disease, factor VII measurement	ITCH BUD13 APOB	7.45e-04	111	47	3	EFO_0001645, EFO_0004619
Disease	erythrocyte measurement	DENND4A BUD13 TAL1 TNS1	7.47e-04	257	47	4	EFO_0005047
Disease	Malignant Neoplasms	SETD2 AHR BIRC6	1.12e-03	128	47	3	C0006826
Disease	cholesteryl ester 18:2 measurement	BUD13 APOB	1.27e-03	33	47	2	EFO_0010345
Disease	cholesteryl ester 18:3 measurement	BUD13 APOB	1.86e-03	40	47	2	EFO_0010346
Disease	Congenital Heart Defects	AHR MAML3	2.25e-03	44	47	2	C0018798
Disease	triacylglycerol 54:4 measurement	BUD13 APOB	2.46e-03	46	47	2	EFO_0010422
Disease	Schizophrenia	CEACAM21 GRIA3 GRIN2A BLOC1S1 GSN KPNA3	2.66e-03	883	47	6	C0036341
Disease	cholesteryl ester 20:3 measurement	BUD13 APOB	2.78e-03	49	47	2	EFO_0010347

Protein segments in the cluster

Peptide	Gene	Start	Entry
QVNGMFENWNSNQFV	AHR	646	P35869
WKQSIGQNYSNVIAN	ARSK	491	Q6UWY0
QWGKGLAQSRQQQQN	BUD13	496	Q9BRD0
GQLVNSSFWQQSNLQ	C1orf167	281	Q5SNV9
LNGNQWSFINNNLHT	BIRC6	2196	Q9NR09
GNQGAAPIQNQQAWQ	CYSRT1	71	A8MQ03
LQVQAAQFAKQTGQW	BLOC1S1	91	P78537
TGTSFQWIFNNQRLQ	CEACAM21	171	Q3KPI0
SQFTLWQQGRRNENA	ASPH	626	Q12797
FDDRNVWFNIQQNNT	CC2D2B	1251	Q6DHV5
LQQQVVWGNRNRNLS	DENND4A	1021	Q7Z401
AVWFLSNITAGNQQQ	KPNA3	346	O00505
RVSNNNQTISGWENG	NGLY1	506	Q96IV0
VQQGAQSWQQRSLQG	MAML3	956	Q96JK9
PQWVAENNFQSFVNA	LRIG3	456	Q6UXM1
GNRTGNNGQIQLWQF	GABPA	311	Q06546
NQGRVNFSWQIQNEQ	GLB1L3	511	Q8NCI6
NAVVRNTQINNSWGS	LGALS9C	276	Q6DKI2
NQNGTFKDWANANVS	LMBRD1	76	Q9NUN5
NAVVRNTQINNSWGS	LGALS9B	276	Q3B8N2
NQPDSKRRQTNNQNW	SYNCRIP	571	O60506
AVQNNWQVTARSVGN	GRIA3	181	P42263
RQTNNQQNWGSQPIA	HNRNPR	586	O43390
NNRIFQWQNVTSFRN	OVOS2	151	Q6IE36
TWAFQRTNQGQDNRR	ELAPOR2	566	A8MWY0
QQQPSGNNRRGWNTT	NUP42	36	O15504
AFNNWGSVEEQRQQQ	GIMAP5	186	Q96F15
NYEQWQLQRSQLQGA	ITCH	396	Q96J02
SAQQASWQVSARFNQ	APOB	3081	P04114
NNVSTQSNGSQQAWG	EPB41L5	396	Q9HCM4
QEVQWRQQAHLGQAF	CROCC2	1631	H7BZ55
QGQIIYNWQGAQSTQ	GSN	486	P06396
QSVNFVNDWQNNSTR	HERVK_113	496	Q902F9
AWNGPQLSSSNNNFQ	S100PBP	206	Q96BU1
FPNQNQTRNCWQNYL	COX6B1	21	P14854
INNWQQLSSFRGQEF	ERCC6L	206	Q2NKX8
RWGNNNRDNNNSNNR	HNRNPUL1	671	Q9BUJ2
DVAQQLWQGQQVQAR	GUCY1A2	501	P33402
SLNWTTQAIQNNREN	PLD6	171	Q8N2A8
NNNTGWKNNGNVNSS	RUSC1	251	Q9BVN2
IRTSFQQQWQNPNEN	RESF1	316	Q9HCM1
FTNSRERWRQQNVNG	TAL1	191	P17542
AHAVQQRQQAVTQAW	SPTBN5	1911	Q9NRC6
RWINNSVFNGNVTNQ	CLEC5A	141	Q9NY25
GWNNTASARNDIQRN	TSPAN13	111	O95857
QRNVHIQESFGQWAN	RILPL1	371	Q5EBL4
EAVQRGLNSWQQQQQ	TNS1	641	Q9HBL0
QGQNYSVWDSNQQSV	SETD2	2266	Q9BYW2
SVRNFEQWQSQRNQL	WWP1	416	Q9H0M0
GQAWNQQGFNQTQSS	TIA1	336	P31483
AVWFLSNITAGNQQQ	KPNA4	346	O00629
ATGEQVYQQDWAQNN	GRIN2A	1261	Q12879